66 results
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
, and may include burdensome post-approval study or risk management requirements. For example, the approved labeling for Gimoti includes a black box warning … stock option award granted was determined on the date of grant using the Black Scholes option-pricing valuation model with the following assumptions
8-K
EX-4.1
EVOK
Evoke Pharma Inc
14 Feb 24
Unregistered Sales of Equity Securities
9:00am
by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant … the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being
424B4
fh0gintswyijskm5
9 Feb 24
Prospectus supplement with pricing info
5:14pm